AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

DEXCOM INC Director's Dealing 2020

Mar 4, 2020

30198_dirs_2020-03-03_7b061b0d-9095-43de-a8a2-b7cb547220b9.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2020-03-02

Reporting Person: MOY JEFFREY (EVP Operations)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-03-02	Common Stock	S	362	$278.1	Disposed	25032	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	30408	Direct

Footnotes

F1: On November 20, 2019, Mr. Moy adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Moy. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F2: Total amount includes transferred shares acquired under the 423 Qualified ESPP Purchase on 2/28/2020.

F3: Shares are held by the Moy Family Trust U/A/D 12/09/2013, with respect to which the reporting person is a trustee.